{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:40:46Z","timestamp":1790066446757,"version":"4.0.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ackdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1053\/j.ackd.2015.06.003","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T02:36:47Z","timestamp":1440383807000},"page":"343-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Glomerular Diseases Associated With Hepatitis B and C"],"prefix":"10.1053","volume":"22","author":[{"given":"Anu","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8546-7528","authenticated-orcid":false,"given":"Richard J.","family":"Quigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7718","key":"10.1053\/j.ackd.2015.06.003_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(71)92572-4","article-title":"Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane","volume":"2","author":"Combes","year":"1971","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.003_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1053\/j.ackd.2015.06.003_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7156\/v4i1p007","article-title":"Global epidemiology of hepatitis B virus (HBV) infection","volume":"4","author":"Hwang","year":"2011","journal-title":"N Am J Med Sci"},{"issue":"9","key":"10.1053\/j.ackd.2015.06.003_bib4","first-page":"666","article-title":"Effect of hepatitis B vaccine immunization on HBV associated nephritis in children","volume":"41","author":"Sun","year":"2003","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.003_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jhep.2005.05.029","article-title":"Hepatitis B virus genotypes and extrahepatic manifestations","volume":"43","author":"Cacoub","year":"2005","journal-title":"J Hepatol"},{"issue":"9","key":"10.1053\/j.ackd.2015.06.003_bib6","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3760\/cma.j.issn.0366-6999.20132765","article-title":"Analysis of pathological data of renal biopsy at one single center in China from 1987 to 2012","volume":"127","author":"Zhang","year":"2014","journal-title":"Chin Med J (Engl.)"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.003_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s004670050492","article-title":"Hepatitis B virus-associated nephropathy in black South African children","volume":"12","author":"Bhimma","year":"1998","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.003_bib8","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1038\/ki.1996.519","article-title":"Detection of hepatitis B virus DNA and RNA in kidneys of HBV related glomerulonephritis","volume":"50","author":"Lai","year":"1996","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ackd.2015.06.003_bib9","first-page":"484","article-title":"Acute immune complex disease associated with hepatitis. Etiopathogenic and immunopathologic studies of the renal lesion","volume":"100","author":"Ozawa","year":"1976","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1053\/j.ackd.2015.06.003_bib10","first-page":"380","article-title":"Characterization of 'e' antigen associated with hepatitis B","volume":"35","author":"Tedder","year":"1979","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.003_bib11","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1073\/pnas.74.4.1702","article-title":"Host specificity of a serum marker for hepatitis B: evidence that \u201ce antigen\u201d has the properties of an immunoglobulin","volume":"74","author":"Neurath","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1053\/j.ackd.2015.06.003_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.1990.32","article-title":"Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations","volume":"37","author":"Johnson","year":"1990","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.003_bib13","first-page":"73","article-title":"Immune complexes in sera of children with HBV-mediated glomerulonephritis","volume":"34","author":"Gregorek","year":"1986","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"2","key":"10.1053\/j.ackd.2015.06.003_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s004670050417","article-title":"In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis","volume":"12","author":"He","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ackd.2015.06.003_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1743-422X-10-300","article-title":"Purified hepatitis B virus induces human mesangial cell proliferation and extracellular matrix expression in\u00a0vitro","volume":"10","author":"Diao","year":"2013","journal-title":"Virol J"},{"issue":"8","key":"10.1053\/j.ackd.2015.06.003_bib16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s00535-011-0415-9","article-title":"Hepatitis B virus X gene and hepatocarcinogenesis","volume":"46","author":"Ng","year":"2011","journal-title":"J Gastroenterol"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.003_bib17","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1046\/j.1523-1755.2002.00287.x","article-title":"HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy","volume":"61","author":"Bhimma","year":"2002","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ackd.2015.06.003_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1399-0039.1998.tb02276.x","article-title":"HLA-DRB and -DQB1 alleles in Polish patients with hepatitis B associated membranous nephropathy","volume":"52","author":"Vaughan","year":"1998","journal-title":"Tissue Antigens"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.003_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1399-0039.2003.00141.x","article-title":"Two subtypes of hepatitis B virus-associated glomerulonephritis are associated with different HLA-DR2 alleles in Koreans","volume":"62","author":"Park","year":"2003","journal-title":"Tissue Antigens"},{"issue":"8","key":"10.1053\/j.ackd.2015.06.003_bib20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ejim.2013.07.009","article-title":"The genotype C could play a key role in hepatitis B virus associated nephritis among the northwest Chinese children","volume":"24","author":"Lei","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"9","key":"10.1053\/j.ackd.2015.06.003_bib21","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/jmv.20941","article-title":"Virological features of hepatitis B virus-associated nephropathy in Japan","volume":"79","author":"Kusakabe","year":"2007","journal-title":"J Med Virol"},{"issue":"3","key":"10.1053\/j.ackd.2015.06.003_bib22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4149\/av_2014_03_278","article-title":"Significance of mutations in hepatitis B virus X gene for the pathogenesis of HB-associated glomerulonephritis","volume":"58","author":"Hui","year":"2014","journal-title":"Acta Virol"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.003_bib23","first-page":"23","article-title":"Membranous glomerulopathy associated with hepatitis B infection","volume":"13","author":"Liu","year":"2008","journal-title":"HK J Paediatr (new series)"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.003_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00868249","article-title":"The clinical course of hepatitis B virus-associated nephropathy","volume":"8","author":"Gilbert","year":"1994","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.003_bib25","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.1989.307","article-title":"Membranous nephropathy in 52 hepatitis B surface antigen (HBsAg) carrier children in Taiwan","volume":"36","author":"Hsu","year":"1989","journal-title":"Kidney Int"},{"issue":"21","key":"10.1053\/j.ackd.2015.06.003_bib26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199105233242103","article-title":"Membranous nephropathy related to hepatitis B virus in adults","volume":"324","author":"Lai","year":"1991","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.003_bib27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.003_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"Huang","year":"2013","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.003_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5414\/CN107615","article-title":"Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy","volume":"78","author":"Li","year":"2012","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2015.06.003_bib30","first-page":"109","article-title":"The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies","volume":"12","author":"Nagy","year":"1979","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.003_bib31","first-page":"229","article-title":"Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas","volume":"29","author":"Lai","year":"1988","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.003_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/0886022X.2013.775659","article-title":"Clinical characteristics and treatment of patients with IgA nephropathy and hepatitis B surface antigen","volume":"35","author":"Sun","year":"2013","journal-title":"Ren Fail"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.003_bib33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10157-008-0124-8","article-title":"Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature","volume":"13","author":"Khaira","year":"2009","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.003_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ki.1995.27","article-title":"Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon","volume":"47","author":"Lin","year":"1995","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ackd.2015.06.003_bib35","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0016-5085(95)90343-7","article-title":"Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa","volume":"109","author":"Conjeevaram","year":"1995","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1053\/j.ackd.2015.06.003_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/0886022X.2012.745785","article-title":"Complete remission of hepatitis B virus-associated nephrotic syndrome from IgA nephropathy following peginterferon therapy","volume":"35","author":"Shah","year":"2013","journal-title":"Ren Fail"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.003_bib37","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/j.1523-1755.2005.00591.x","article-title":"Lamivudine in hepatitis B-associated membranous nephropathy","volume":"68","author":"Tang","year":"2005","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ackd.2015.06.003_bib38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0929-6646(08)60054-6","article-title":"Complete remission of nephrotic syndrome of hepatitis B virus-associated membranous glomerulopathy after lamivudine monotherapy","volume":"106","author":"Chuang","year":"2007","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"10.1053\/j.ackd.2015.06.003_bib39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3748\/wjg.v18.i8.821","article-title":"Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis","volume":"18","author":"Zheng","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1053\/j.ackd.2015.06.003_bib40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/kisup.2012.22","article-title":"Chapter 9: Infection-related glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int Suppl (2011)"},{"issue":"4902","key":"10.1053\/j.ackd.2015.06.003_bib41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.003_bib42","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/infdis\/169.6.1219","article-title":"Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease","volume":"169","author":"Gretch","year":"1994","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.003_bib43","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/0272-6386(95)90557-X","article-title":"Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection","volume":"25","author":"Quigg","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ackd.2015.06.003_bib44","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/ki.2014.181","article-title":"Novel evidence on hepatitis C virus-associated glomerular disease","volume":"86","author":"Fabrizi","year":"2014","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.003_bib45","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MAJ.0b013e318293cdee","article-title":"Hepatitis C virus-related heat-insoluble cryoglobulinemia and thrombotic microangiopathy","volume":"346","author":"Wu","year":"2013","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.003_bib46","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.1840360621","article-title":"Extrahepatic manifestations of hepatitis C among United States male veterans","volume":"36","author":"El-Serag","year":"2002","journal-title":"Hepatology"},{"issue":"10","key":"10.1053\/j.ackd.2015.06.003_bib47","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2169\/internalmedicine.37.836","article-title":"Glomerulonephritis in autopsy cases with hepatitis C virus infection","volume":"37","author":"Arase","year":"1998","journal-title":"Intern Med"},{"issue":"10","key":"10.1053\/j.ackd.2015.06.003_bib48","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-144-10-200605160-00007","article-title":"Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation","volume":"144","author":"McGuire","year":"2006","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.003_bib49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2215\/CJN.06920711","article-title":"Hepatitis C virus infection and kidney disease: a meta-analysis","volume":"7","author":"Fabrizi","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ackd.2015.06.003_bib50","first-page":"695","article-title":"Hepatitis C virus-related mixed cryoglobulinemia: pathogenesis, clinical manifestations, and new therapies","volume":"3","author":"Schamberg","year":"2007","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"5386","key":"10.1053\/j.ackd.2015.06.003_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in\u00a0vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.003_bib52","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0168-8278(03)00075-8","article-title":"Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver","volume":"38","author":"Curry","year":"2003","journal-title":"J Hepatol"},{"issue":"7","key":"10.1053\/j.ackd.2015.06.003_bib53","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/ndt\/gfm205","article-title":"Hepatitis C virus: from entry to renal injury\u2014facts and potentials","volume":"22","author":"Barsoum","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.003_bib54","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","article-title":"Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage","volume":"106","author":"Lunel","year":"1994","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1053\/j.ackd.2015.06.003_bib55","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/1529-0131(200109)44:9<2118::AID-ART364>3.0.CO;2-X","article-title":"Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia","volume":"44","author":"Cacoub","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1053\/j.ackd.2015.06.003_bib56","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"6 Suppl 32","key":"10.1053\/j.ackd.2015.06.003_bib57","first-page":"S101","article-title":"Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations","volume":"21","author":"Vassilopoulos","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1053\/j.ackd.2015.06.003_bib58","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.dld.2014.05.017","article-title":"Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study","volume":"46","author":"Gragnani","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.003_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/kel177","article-title":"Hepatitis C virus-associated B-cell proliferation\u2014the role of serum B lymphocyte stimulator (BLyS\/BAFF)","volume":"46","author":"Sene","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.003_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/rheumatology\/kel174","article-title":"B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection","volume":"46","author":"Fabris","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.003_bib61","first-page":"531","article-title":"Glomerulonephritis induced by human IgMK-IgG cryoglobulins in mice","volume":"69","author":"Fornasieri","year":"1993","journal-title":"Lab Invest"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.003_bib62","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1523-1755.2004.00495.x","article-title":"Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis","volume":"65","author":"Muhlfeld","year":"2004","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2015.06.003_bib63","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jhep.2004.11.034","article-title":"Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia","volume":"42","author":"Kaplanski","year":"2005","journal-title":"J Hepatol"},{"issue":"3","key":"10.1053\/j.ackd.2015.06.003_bib64","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2249.2005.02778.x","article-title":"Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection","volume":"140","author":"Sansonno","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.003_bib65","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2005.01.013","article-title":"HCV associated glomerulopathy in Egyptian patients: clinicopathological analysis","volume":"334","author":"Sabry","year":"2005","journal-title":"Virology"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.003_bib66","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1046\/j.1523-1755.1999.00769.x","article-title":"Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study","volume":"56","author":"Laurinavicius","year":"1999","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2015.06.003_bib67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2006.09.015","article-title":"Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis","volume":"49","author":"Roccatello","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2015.06.003_bib68","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000348477","article-title":"Hepatitis C virus-associated glomerulonephritis","volume":"181","author":"Tang","year":"2013","journal-title":"Contrib Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2015.06.003_bib69","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ki.1995.78","article-title":"Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis","volume":"47","author":"Tarantino","year":"1995","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2015.06.003_bib70","first-page":"S1","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"109","year":"2008","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.003_bib71","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0272-6386(03)00828-X","article-title":"Hepatitis C and renal disease: an update","volume":"42","author":"Meyers","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ackd.2015.06.003_bib72","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1681\/ASN.V1071566","article-title":"Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection","volume":"10","author":"Cheng","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2015.06.003_bib73","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5414\/CN107774","article-title":"The changing pattern of glomerular disease in HIV and hepatitis C co-infected patients in the era of HAART","volume":"79","author":"Mohan","year":"2013","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2015.06.003_bib74","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/039139880703000306","article-title":"Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials","volume":"30","author":"Fabrizi","year":"2007","journal-title":"Int J Artif Organs"},{"issue":"9138","key":"10.1053\/j.ackd.2015.06.003_bib75","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.ackd.2015.06.003_bib76","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0272-6386(99)70140-X","article-title":"Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy","volume":"33","author":"Ohta","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ackd.2015.06.003_bib77","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10620-013-2959-4","article-title":"De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review)","volume":"59","author":"Fabrizi","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.003_bib78","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/1529-0131(199905)42:5<1051::AID-ANR26>3.0.CO;2-Q","article-title":"Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity","volume":"42","author":"Cid","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1053\/j.ackd.2015.06.003_bib79","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1053\/j.ackd.2015.06.003_bib80","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2015.06.003_bib81","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.ackd.2015.06.003_bib82","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1002\/art.25000","article-title":"Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis","volume":"60","author":"Sene","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559515000853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559515000853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T18:05:12Z","timestamp":1718042712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559515000853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1548559515000853"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2015.06.003","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glomerular Diseases Associated With Hepatitis B and C","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2015.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}